MedTrace Logo

PUFAs in Preterm Infants

NCT06045130 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2023-09-21

No results posted yet for this study

Summary

The research endeavors to examine the critical composition of Polyunsaturated Fatty Acids (PUFAs) in premature infants across different gestational stages and under varying disease conditions, and delineate the metabolic attributes of PUFAs in premature infants and their interplay with the onset of diseases. This study anticipates furnishing a theoretical foundation for the rationalization of PUFAs supplementation in premature infants and for informing strategies related to disease prevention and management.

Conditions

  • Necrotizing Enterocolitis
  • Intraventricular Hemorrhage
  • BPD - Bronchopulmonary Dysplasia
  • Sepsis
  • Periventricular Leukomalacia
  • Patent Ductus Arteriosus

Sponsors & Collaborators

  • The First Hospital of Jilin University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-21
Primary Completion
2026-08-31
Completion
2026-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06045130 on ClinicalTrials.gov